Introducing IndieBio Class Six
Today we are extremely excited to announce the fourteen startups joining IndieBio Class Six in downtown San Francisco.
At IndieBio, we are on a mission to solve the world’s biggest and toughest problems by using biology as a technology. We are giving scientists the resources they need to drive innovations across food, biopharma and healthcare, agtech, regenerative medicine, neurotech, biomaterials and beyond.
When we first introduced the first class in 2015, we made a bet that scientists are more creative, driven and entrepreneurial than most VCs give them credit for. IndieBio was built on the belief that with the right environment and structure, scientists can make the shift to entrepreneurs and build transformational companies. Three years later, we are amazed at the results: we’ve had the privilege of working with 81 of of the most exciting companies in the world and playing a role in their growth — including Memphis Meats (cultured meat), Koniku (biological neurochips), SyntheX Therapeutics (peptide therapeutics), Catalog (data storage in DNA), Ava Winery (engineered wine) and Qidni Labs (implantable artificial kidneys). We are proud to have created a repeatable design-driven process to enable scientists to productize their discovery.
Class Six is comprised of startups in therapeutics, cell therapies, food & agriculture, and diagnostics for cancer and neurological disease hailing from all over the world. More than ever the IndieBio teams are on the cutting edge of science and solving massive problems in the world today.
Delivering AI-powered decision support software designed to monitor and reduce antibiotic resistance.
Developing smart and strong bees for crop pollination. With their technologies, farmers can increase crop yields up to 90%, target specific crops for pollination, and substantially reduce bee population decline.
Leading the next generation of multiplexed in situ single-cell RNA analysis tools for research and diagnostic applications.
Pioneering access to high quality fat grafts, fat-derived stem cells and cell therapies. Their device enables doctors, clinics and hospitals to provide safe and cost-effective non-surgical treatments for patients.
Creating ‘wood’ without the tree. Their formable, natural fiber and resin replicates the performance, look, feel and re-usability of premium wood from scalable, carbon negative materials.
MezoMax enables faster bone fracture healing, improved osteoporosis treatment, and stronger bones in elderly patients with their novel calcium gluconate stereoisomer, which regulates calcium and mineral metabolism.
Developing long acting non-opioid chronic pain medications. Its novel delivery system eliminates addiction potential and side effects that are seen across all opioids.
Nivien Therapeutics is developing the first small molecule drugs to enhance both chemo and immunotherapies. Their compounds overcome multiple resistance mechanisms across 15 cancers to increase efficacy and decrease toxicity of treatments.
Nuro enables instant communication and computing for millions of incapacitated patients in post-surgeries and ICUs, nursing homes and rehabilitation by using brain signals.
Onconetics Pharmaceuticals develops gene therapies which target tumor cells with specific gene expression profiles. The effector arm of the therapy involves a genetic switch which activates an apoptotic inducer to kill the cancer cell and spares healthy tissue.
sRNAlytics has developed a novel bioinformatics platform to identify error-free, small RNA biomarkers. Their Proof-of-Concept work in Huntington’s Disease validated eight biomarkers that are 100% accurate for classifying early vs. late stage disease, and disease progression.
Sun Genomics is a microbiome health company focused on curing dysbiosis through personalized probiotics. Their platform enables the highest resolution profiling of customer gut makeup, empowering them to make and track changes over time.
Terramino Foods is reimagining seafood, using fungi and algae to make healthy, affordable, and toxin-free products.
Vetherapy creates novel stem cell therapies for cats, dogs, and horses. Their most innovative product speeds up wound healing and treats autoimmune and inflammatory diseases.
IndieBio is the world’s leading life sciences accelerator, having funded 81biotech startups since starting in March 2015. Companies from all over the world apply to be part of a 4 month acceleration program which includes $250,000 funding, dedicated mentorship, and 24/7 access to a co-working space and bio-safety level 1 & 2 labs. During the program, teams are focused on turning science into product, closing customers, and raising follow-on investment.
Apply here to be in our next class!